Brandon Garriga, MD
Pulmonary Disease · Jackson, MSNPI 1275820847
Payments from drug & device makers
Across 461 payments — averaging $16.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$4K
- AstraZeneca$600
- Boehringer Ingelheim$500
- Actelion Pharmaceuticals US, Inc.$378
- Insmed, Inc.$264
- Mylan Specialty L.p.$261
- plus $2K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 249 | $3,759 |
| AstraZeneca | 28 | $600 |
| Boehringer Ingelheim | 32 | $500 |
| Actelion Pharmaceuticals US, Inc. | 20 | $378 |
| Insmed, Inc. | 18 | $264 |
| Mylan Specialty L.p. | 15 | $261 |
| Bayer | 4 | $259 |
| Mallinckrodt Hospital Products Inc. | 9 | $187 |
| Genentech USA, Inc. | 11 | $174 |
| AbbVie(2 entities) | 7 | $151 |
| Electromed, Inc. | 11 | $149 |
| Gilead | 9 | $146 |
| Inari Medical, Inc. | 9 | $136 |
| Sanofi | 7 | $125 |
| Regeneron Healthcare Solutions, Inc. | 5 | $116 |
| Grifols USA, LLC | 6 | $108 |
| Sunovion Pharmaceuticals Inc. | 4 | $82 |
| Ambu Inc. | 2 | $54 |
| 3b Medical, Inc. | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Merck | 2 | $28 |
| Novartis | 2 | $28 |
| La Jolla Pharmaceutical Company | 2 | $25 |
| Philips North America LLC | 1 | $22 |
| Jazz Pharmaceuticals Inc. | 1 | $20 |
| Boston Scientific | 1 | $17 |
| Shire North American Group Inc | 1 | $14 |
| Pfizer | 1 | $11 |
How this compares
$7,700 in reported general payments places this provider in the 55th percentile of 101 pulmonary disease providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Jackson
- Demondes HaynesJackson$809K
- Michal SenitkoJackson$355K
- Andrew WilhelmJackson$164K
- Maria RappaiJackson$45K
- Raymond PortisJackson$39K
- Kimberly DobbsJackson$35K
- George AbrahamJackson$23K
- Arash SamarghandiJackson$19K
- Richard WellsJackson$19K
- Rajesh PatelJackson$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.